Shares of Amgen Inc. AMGN, +0.47% rose 2% in the extended session Tuesday after the pharma giant reported third-quarter profits and sales above Wall Street expectations and revised up its guidance for the year. Amgen said it earned $1.86 billion, or $2.86 a share, in the quarter, compared with $2.02 billion, or $2.76 a share, in the year-ago quarter. Adjusted for one-time items, Amgen earned $2.39 billion, or $3.69 a share, compared with $3.27 a share a year ago. Revenue increased 2% to $5.9 billion, from $5.8 billion a year ago. Analysts polled by FactSet had expected Amgen to report adjusted earnings of $3.45 a share on sales of $5.8 billion. Amgen said it expects full-year 2018 sales between $23.2 billion and $23.5 billion, up from a previous guidance of sales between $22.5 billion and $23.2 billion. Adjusted per-share earnings are seen between $14 a share and $14.25 a share for the year, compared with expectations of non-GAAP EPS between $13.30 and $14. Shares of Amgen ended the regular trading session up 0.5%.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.